ArticleJournal for immunotherapy of cancer2017

Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies.

Matthew J Reilley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.